Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001326990 | SCV001518047 | uncertain significance | Biotinidase deficiency | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 417 of the BTD protein (p.Val417Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with BTD-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001326990 | SCV003830198 | uncertain significance | Biotinidase deficiency | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001326990 | SCV002081574 | uncertain significance | Biotinidase deficiency | 2020-08-24 | no assertion criteria provided | clinical testing |